Drugs & Targets Array BioPharma, Merck collaborate to study MEK inhibitor with Keytruda May 12, 2017Vol.43 No.19
Drugs & Targets OncoSec, Merck to evaluate ImmunoPulse IL-12 and Keytruda in metastatic melanoma May 12, 2017Vol.43 No.19
Drugs & Targets Regeneron, SillaJen to test combination treatment in kidney cancer May 12, 2017Vol.43 No.19
Drugs & Targets Regeneron, Inovio agree to study glioblastoma combination therapy May 12, 2017Vol.43 No.19
Drugs & Targets FDA grants an accelerated approval for AstraZeneca’s Imfinzi for urothelial carcinoma May 05, 2017Vol.43 No.18
Drugs & Targets Draft Local Coverage Determination favorable to Oncotype DX Genomic Prostate Score May 05, 2017Vol.43 No.18
Drugs & Targets Opdivo gets European approval for squamous cell head and neck cancer May 05, 2017Vol.43 No.18
Drugs & Targets Tecentriq receives accelerated approval as initial treatment for advanced bladder cancer May 01, 2017Vol.40 No.04
Drugs & Targets FDA approves midostaurin combination for AML; Companion diagnostic also approved April 28, 2017Vol.43 No.17
Drugs & Targets FDA expands indications for regorafinib in hepatocellular carcinoma April 28, 2017Vol.43 No.17
